购物车
- 全部删除
- 您的购物车当前为空
DSS30 是一种 P25/CDK5抑制剂。DSS30通过抑制淀粉样前体蛋白裂解酶1 (BACEl) 磷酸化,减少 β-淀粉样蛋白 (Aβ) 的分泌发挥作用。DSS30 可用于预防和治疗阿尔茨海默病等神经退行性疾病。
为众多的药物研发团队赋能,
让新药发现更简单!
DSS30 是一种 P25/CDK5抑制剂。DSS30通过抑制淀粉样前体蛋白裂解酶1 (BACEl) 磷酸化,减少 β-淀粉样蛋白 (Aβ) 的分泌发挥作用。DSS30 可用于预防和治疗阿尔茨海默病等神经退行性疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,350 | 现货 | |
5 mg | ¥ 5,630 | 现货 | |
10 mg | ¥ 7,790 | 现货 | |
25 mg | ¥ 11,200 | 现货 | |
50 mg | ¥ 13,800 | 现货 | |
100 mg | ¥ 17,500 | 现货 | |
500 mg | ¥ 34,800 | 现货 |
产品描述 | DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of β-amyloid (Aβ).DSS30 can be used for the prevention and treatment of neurodegenerative diseases such as Alzheimer's disease. |
体外活性 | DSS30 (50 μM, 2 h) demonstrates a maximum 50% inhibition in the P25/CDK5 complex activity, along with a reduction in the phosphorylation levels of BACE1 or Tau.[1] |
分子量 | 367.87 |
分子式 | C16H14ClNO3S2 |
CAS No. | 883027-32-5 |
Smiles | CC=1C=2C(SC1S(NC3=C(OC)C=CC=C3)(=O)=O)=CC=C(Cl)C2 |
存储 | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 10 mg/mL (27.18 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容